Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Martin Kast

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
Current Opinion in Oncology|November 1, 2002
Emerging strategies in tumor vaccinesI Caroline Le Poole, M A Todd Gerberi, W Martin Kast
Methods in Molecular Medicine|February 11, 2012
Molecular characterization of melanoma-derived antigensM Visser, M P Velders, M P Rudolf, et al.
Expert Opinion on Biological Therapy|March 5, 2004
Peptide-based vaccines for cancer immunotherapyJoeli A Brinkman, Steven C Fausch, Jeffrey S Weber, et al.
Journal of Translational Medicine|October 25, 2006
Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvantYi T Koh, Sean A Higgins, Jeffrey S Weber, et al.
Cancers|September 9, 2022
Investigation of the Optimal Prime Boost Spacing Regimen for a Cancer Therapeutic Vaccine Targeting Human PapillomavirusDiane M Da Silva, Emma A Martinez, Lies Bogaert, et al.
International Reviews of Immunology|September 10, 2003
CD4+ T cell matters in tumor immunityMarkwin P Velders, Mary A Markiewicz, Gretchen L Eiben, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2014
Functional analysis of HPV-like particle-activated Langerhans cells in vitroLisa Yan, Andrew W Woodham, Diane M Da Silva, et al.
Cancer Immunity|April 25, 2008
Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccinesMaurizio Chiriva-Internati, Everardo Cobos, Diane M Da Silva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomavirusesSteven C Fausch, Diane M Da Silva, Michael P Rudolf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16Laura M Fahey, Adam B Raff, Diane M Da Silva, et al.
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
Current Opinion in Oncology|November 1, 2002
Emerging strategies in tumor vaccinesI Caroline Le Poole, M A Todd Gerberi, W Martin Kast
Methods in Molecular Medicine|February 11, 2012
Molecular characterization of melanoma-derived antigensM Visser, M P Velders, M P Rudolf, et al.
Expert Opinion on Biological Therapy|March 5, 2004
Peptide-based vaccines for cancer immunotherapyJoeli A Brinkman, Steven C Fausch, Jeffrey S Weber, et al.
Journal of Translational Medicine|October 25, 2006
Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvantYi T Koh, Sean A Higgins, Jeffrey S Weber, et al.
Cancers|September 9, 2022
Investigation of the Optimal Prime Boost Spacing Regimen for a Cancer Therapeutic Vaccine Targeting Human PapillomavirusDiane M Da Silva, Emma A Martinez, Lies Bogaert, et al.
International Reviews of Immunology|September 10, 2003
CD4+ T cell matters in tumor immunityMarkwin P Velders, Mary A Markiewicz, Gretchen L Eiben, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2014
Functional analysis of HPV-like particle-activated Langerhans cells in vitroLisa Yan, Andrew W Woodham, Diane M Da Silva, et al.
Cancer Immunity|April 25, 2008
Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccinesMaurizio Chiriva-Internati, Everardo Cobos, Diane M Da Silva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomavirusesSteven C Fausch, Diane M Da Silva, Michael P Rudolf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16Laura M Fahey, Adam B Raff, Diane M Da Silva, et al.
Pageof 14